Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

M Pharmaceutical eyeing 40 J’s acquisition closure by mid-February

Friday, February 10, 2017 7:31
% of readers think this story is Fact. Add your two cents.

Drugs firm M Pharmaceutical Inc (CSNX:MQ, OTCMKTS:MPHMF) provided an update on corporate activity and product development, including that its deal to buy  Cincinnati-based 40 J’s announced last year is expected to close by the middle of this month (February).

With the closure of that acquisition, the firm gains seven different products, which are FDA cleared, and will provide revenue streams.

Some are currently distributed in China through an agreement with a third party, with current revenues to 40 Js of around US$800,000 per year.

On its Orlistat (C-103)  slimming product program, the firm said the PIND (Pre-Investigational New Drug Application)  package has been completed and delivered to the FDA investigator, who is scheduled to respond by March 6, 2017.

Then the group should have an approved path including particulate partners and study requirements, it added.

The firm also acquired the global marketing rights to ToConceive in November last year.

With this product, a strategic brief and brand model is scheduled for Wednbesday (February 14) this year and online sales should launch in late April or May, 2017 with targeted sales of 2,000 units per month initially, the group said.

On the group’s female dysfunction group,the original provisional patent application was submitted to the USPTO in April, 2015 and the firm  anticipates hearing from the USPTO by May, 2017.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.